Half of Youth-Serving Clinicians Screen for Substance Use Disorder at Every Well Visit
Fewer report using a screening tool at every well visit
FDA Warns of Heart Risk With Pfizer, Moderna COVID Vaccines
Residual Inflammation Seen in One-Third of Patients With Psoriasis on Biologics
Residual inflammation significantly linked to higher BMI, metabolic dysfunction-associated steatotic liver disease, baseline systemic inflammation
Lipoprotein(a) Levels Tied to Increased Risk of Recurrent Atherosclerotic CVD Events
Deleterious effect of lipoprotein(a) ≥180 nmol/L possibly mitigated by high-impact LDL-cholesterol-lowering therapy
FDA Limits COVID-19 Boosters to Seniors, Other High-Risk Groups
FDA Approves Zynyz as First-Line Treatment for Advanced Anal Cancer
The programmed death receptor-1-blocking antibody is approved as a single agent or in combination with chemotherapy
No Increase Seen in Neurodevelopmental Disorders With Prenatal Triptan Use
No significantly increased risk seen with exposure to different triptan intensities and duration, alone or in combination with other preventive medications
Exposure to Certain HIV Drugs May Significantly Lower Risk for Alzheimer Disease
Nucleoside reverse transcriptase inhibitors appear to be neuroprotective, thus lowering the incidence of Alzheimer dementia
Topical Testosterone + Exercise No Aid for Hip Fracture Recovery in Women
Findings compared with exercise therapy alone or usual care among older women
Methotrexate Noninferior to Prednisone in Pulmonary Sarcoidosis
Methotrexate noninferior to prednisone with regard to change from baseline to week 24 in percentage of predicted forced vital capacity
